Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intensity-Modulated Radiotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01882816
What this trial is testing

Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer

Who this might be right for
Thyroid Cancer
Memorial Sloan Kettering Cancer Center 27
Early research (Phase 1)Study completedNCT01043536
What this trial is testing

Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults

Who this might be right for
Glioblastoma
Centre Georges Francois Leclerc 10
Not applicableUnknownNCT01730651
What this trial is testing

High Dose Intensity Modulated Radiation Therapy in the Cervical Cancer With Metastatic Lymphadenopathies.

Who this might be right for
Cervical Cancer
National Cancer Center, Korea 55
Not applicableActive Not RecruitingNCT04658537
What this trial is testing

Advanced Techniques for Single-fraction Palliative Radiotherapy Versus ASPIRE-single

Who this might be right for
Palliative RadiotherapyRadiotherapy, Intensity-Modulated
Royal North Shore Hospital 100
Large-scale testing (Phase 3)Study completedNCT01812486
What this trial is testing

Dose De-escalation to the Elective Nodal Sites in Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Universitaire Ziekenhuizen KU Leuven 200
Early research (Phase 1)Study completedNCT01470365
What this trial is testing

3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Recurrent Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Fox Chase Cancer Center 24
Not applicableLooking for participantsNCT07483658
What this trial is testing

Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.

Who this might be right for
Reccurent/Metastatic Solid Tumor DiseaseProstate Cancer (Post Prostatectomy)Prostate Cancer+3 more
CHU de Quebec-Universite Laval 434
Not applicableEnded earlyNCT00568425
What this trial is testing

QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT

Who this might be right for
Anal Cancer
Stanford University 10
Testing effectiveness (Phase 2)UnknownNCT01117402
What this trial is testing

Tomotherapy in Postsurgery Recurrent Carcinoma Cervix

Who this might be right for
Postsurgery Recurrent Carcinoma Cervix
Tata Memorial Hospital 90
Testing effectiveness (Phase 2)WithdrawnNCT01409473
What this trial is testing

Stereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Rocky Mountain Cancer Centers
Early research (Phase 1)UnknownNCT05299203
What this trial is testing

BH4 in the Prevention and Treatment of Radiation-induced Skin Reactions for Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
West China Hospital 18
Early research (Phase 1)Ended earlyNCT01367990
What this trial is testing

Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy

Who this might be right for
AlopeciaRadiodermatitis
ProCertus BioPharm, Inc 3
Testing effectiveness (Phase 2)Study completedNCT00576979
What this trial is testing

Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Leukemia
City of Hope Medical Center 51
Testing effectiveness (Phase 2)Study completedNCT00520702
What this trial is testing

3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 168
Early research (Phase 1)Study completedNCT03269422
What this trial is testing

Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL)

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 35
Early research (Phase 1)Study completedNCT00168129
What this trial is testing

Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases

Who this might be right for
Bone Neoplasms
Alberta Health services 10
Early research (Phase 1)Study completedNCT01395667
What this trial is testing

Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy in Combination With Bevacizumab-FOLFOX

Who this might be right for
Rectal Cancer
National Taiwan University Hospital 15
Not applicableActive Not RecruitingNCT03181477
What this trial is testing

Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas

Who this might be right for
Glioblastoma, Adult
Centre Georges Francois Leclerc 67
Early research (Phase 1)Study completedNCT00736619
What this trial is testing

Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
HEAD & NECK Cancer
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00551525
What this trial is testing

Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 67
Next Page